Close Menu

Tempus xE Whole-Exome Tumor Sequencing

Feb 22, 2018

Personalized cancer technology company Tempus has introduced Tempus xE, a whole-exome sequencing panel that analyzes tumor DNA alongside a normal sample and a whole-RNA transcriptome. The new CLIA/CAP-validated assay gives researchers and clinicians a broad view of potential tumor mutations and treatment pathways, Tempus said. 

More Like This

Jun 25, 2019

GenScript Enhanced GenBrick Gene Synthesis Service

GenScript has launched an upgrade to its GenBrick Gene Synthesis platform, which gives researchers access to DNA sequences up to 200 kilobases long with 100 percent accuracy. GenScript said it has optimized the genome assembly process and enhanced its technology to better handle difficult sequences. It has also developed new technology to quickly and accurately create long DNA sequences in one step that are free of any mutations or negative clones. 

The GenBrick service has been tested and used in synthetic biology projects such as the Synthetic 2.0 Yeast Genome (Sc2.0) project, where it synthesized the long arm of yeast chromosome VI. 

Jun 24, 2019

Phitonex NovaFluor Dyes

Phitonex has launched a new suite of NovaFluor dyes, which the firm said allows researchers to rapidly increase the number of scientific questions they can answer per cell on extant flow cytometry instrumentation. According to Phitonex, the platform helps engineer optical properties to provide high resolution single cell analysis with flow cytometry. 

Jun 20, 2019

Phase Genomics ProxiMeta Platform

Phase Genomics has launched its new ProxiMeta platform, which includes a 8-pack ProxiMeta kit with cloud-based ProxiMeta Analysis. According to the firm, the platform allows users to assemble hundreds of genomes and associated plasmids, phages, and antibiotic resistance, and interactions between genetic elements in microbial cells and communities. Phase said that the eight-reaction kit uses improved chemistry, includes reagents needed to prepare a sequencing-ready library from a microbiome sample, and does not require specialized equipment.

According to the firm, applications include antimicrobial resistance genes discovery, capturing phage and horizontal gene transfer, understanding the relationship between the microbiome and the resistome, and high-quality metagenome assembly from microbiome samples.

Jun 20, 2019

Fluidigm Maxpar Imaging Mass Cytometry Kits; CyTOF Software; Labeling Kits

Fluidigm is launching a number of mass cytometry products in the third quarter. Three Imaging Mass Cytometry Maxpar panel kits are designed for immune-oncology research. Developed using pathologist-verified antibodies, the panels can be mixed and matched to profile tumor-infiltrating lymphocytes, immune cell activation states, and tissue architecture. By combining them as a single 18-marker panel, researchers can broadly profile activated tumor-infiltrating lymphocytes for single-cell analysis of tumor architecture from a single tissue scan, Fluidigm said.

 

In addition, Fluidigm will introduce new CyTOF software, designed to be used with the Hyperion Imaging System for cellular biomarker identification. According to the firm, the software streamlines the selection and acquisition of multiple regions of interest (ROI) from each slide. Researchers can remotely annotate those ROIs using brightfield reference images to guide automated batch acquisition of highly multiplexed images at 1-micron resolution. During image acquisition, researchers can visualize multiplexed images in real time across all detection channels to ensure data quality, Fluidigm said.

 

Finally, the company will introduce seven new cadmium metal labeling kits for mass cytometry. The isotopes are the first of a new series in development and will allow researchers to design and customize larger panels to advance biomarker discovery and therapeutic development, Fluidigm said.

Jun 19, 2019

Cytek Biosciences Aurora Flow Cytometer

Cytek Biosciences is launching the latest version of its Cytek Aurora flow cytometry system featuring five lasers and the ability to detect more than 30 colors from a single sample without changing optical filters. The system can be used with any fluorochromes excited by the onboard lasers, and offers high resolution of dim and rare populations, Cytek said. The system simplifies workflows, saves costs, and allows access to a greater choice of dyes and specificities for applications that require deep profiling of cell populations in a single sample, the company added.

Jun 19, 2019

BGI 676 Quality Genome Standard

BGI has introduced the 676 Quality Genome, a new standard and cost-effective solution for high quality de novo genome assembly using MGI's DNBSEQ and stLFR technologies. BGI defined the standard as having a contig N50 greater than 106 bases (>1Mb), scaffold N50 greater than 107 bases (>10 Mb), and, for the human genome, total assembled size larger than 6 Gb. The firm expects the standard's cost to be $1,000, on the upcoming MGISEQ-T7 sequencing platform.

According to BGI, the 676 Quality Genome can detect all types of structural variants and is ideal for assembling regions of the genome not well represented by the reference genome. The firm said that the 676 Quality Genome provides more accurate and comprehensive genetic predictions, since it assembles each person's genome individually and does not depend on a reference genome.

Jun 18, 2019

Biocept NGS Breast Panel

Biocept has launched its second multi-gene liquid biopsy product, the Target Selector NGS Breast Panel, which is run on Thermo Fisher Scientific's Ion Torrent next generation sequencing platform and is designed to enable the detection and monitoring of actionable genomic biomarkers associated with breast cancer. The company said the test, which will be marketed to physicians and researchers, has shown over 99 percent sensitivity with at least 90 percent specificity in internal validations. 

Jun 17, 2019

Qiagen Microbial Insights AR

Qiagen has launched Microbial Insights AR (QMI-AR), an integrated genomic database that provides curated, single-point entry access to four of the world's largest knowledgebases on antimicrobial resistance. Specifically, it integrates the Comprehensive Antibiotic Resistance Database (CARD), ResFinder, a National Institutes of Health AMRFinder database of resistance genes, as well as the ARG-ANNOT database of peptide markers. According to Qiagen, the database complements ARESdb, a comprehensive, regularly updated genomic knowledgebase on clinically relevant antibiotic resistance strains that the firm has made available to the global research community through a partnership with Ares-Genetics, a Curetis subsidiary. Qiagen said that it will offer QMI-AR through the CLC Microbial Genomics Module, an extension to the CLC Genomics Workbench bioinformatics software.

Jun 17, 2019

GeneCast RUO Kits

Chinese liquid biopsy firm GeneCast has launched a set of research-use-only kits for BRAF, EGFR, and JAK2 mutation detection. The firm claims technical sensitivity for the BRAF assay as low as 0.0001 percent, and for the EGFR and JAK2 kits of 0.01 percent. The products use the company's ADPS quantitative PCR method, and the firm said it is working on gaining approval to offer the products for clinical use, filing a PMA submission with the US Food and Drug Administration, for the EGFR assay for example. GeneCast plans to launch additional RUO kits for KRAS, NRAS, PIK3CA, pTERT, IDH1, and IDH2 by the end of this year.

Jun 17, 2019

Twist Bioscience Mouse Core Exome Panel

Twist Bioscience has launched the Mouse Core Exome Panel for target enrichment in next-generation sequencing. The comprehensive panel for research use is built from the most current databases.

Jun 17, 2019

Paragon Genomics CleanPlex NGS Panels

Paragon Genomics has launched a series of CleanPlex products for MGI sequencers. The firm now offers its CleanPlex for MGI Ready-to-Use NGS panels, which can be used for both MGI's OncoZoom Cancer Hotspot Panel and MGI's BRCA1 and BRCA2 Panel. Paragon also offers its CleanPlex for MGI Custom NGS panels, which allow researchers to build customized assays to address specific needs. The firm noted that its support staff will take custom orders, developing and delivering panels that are completely compatible with MGISEQ sequencers. In addition, Paragon is offering validated automation protocols ensuring that CleanPlex for MGI assays can work with the MGISP-960 Automated Sample Preparation System to produce the same results performed if done manually. 

Jun 14, 2019

BGI Whole Exome Sequencing Service

BGI Genomics has launched a clinical research whole exome sequencing service called BGI-Xome, which incorporates clinical interpretation services from UK-based Congenica. BGI will perform WES at its service laboratories, while interpretation will be completed by clinical scientists using the Congenica clinical decision support platform. According to BGI, Congenica's Interpretation platform will allow its service to provide a "gold-standard" and effective solution that eliminates the risk of users missing or misidentifying disease-linked mutations. 

Jun 13, 2019

Oxford Gene Technology SureSeq NGS Library Prep Kit

Oxford Gene Technology has released a new SureSeq library preparation kit for hybridization-based target capture in next-generation sequencing. According to the firm, the kit offers a streamlined protocol with enrichment by hybridization with a ready-to-use hybridization and wash buffer. It also reduces manual handling steps to increase reliability and throughput. The firm also said that the kit lowers duplication rates, leading to more accurate calling and more even coverage.

Jun 12, 2019

Patients Choice Laboratories UTI+ Test

Patients Choice Laboratories has launched the UTI+ molecular test for urinary tract infections. The Indianapolis-based company said the new test is part of its goal to be a full-service lab. It added that its gene- and molecular-based technologies provides uropathogenic and antibiotic resistance testing results within six hours after specimen receipt compared to up to three days with urinalysis by culturing. 

Jun 11, 2019

Genestack Omics Data Manager

Genestack has introduced Omics Data Manager, a system for cataloguing, curating, indexing, searching, and sharing multi-omics data. Omics Data Manager can serve as centralized repository for enterprises looking to implement the FAIR (Findable, Accessible, Interoperable, and Reusable) principles for biomedical data management. Omics Data Manager can be integrated into laboratory information management systems and third-party, upstream data analysis platforms, according to Cambridge, UK-based Genestack. 

New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.

A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.

Broad Institute researchers describe an approach they've dubbed "DNA microscopy."

In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
24
Sponsored by
Hologic

This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).

Jul
25
Sponsored by
Roche

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.